文献速递肝病消化道肿瘤与早癌

基层医疗提供者对肝细胞癌监测的实践模式与障碍

Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-07-26

该研究于2017年6月至12月对2家三级转诊中心的133名基层医疗提供者进行网络调查,应答率75%。多数提供者认为超声联合甲胎蛋白检测高效,但对非酒精性脂肪性肝炎或失代偿期肝硬化患者更倾向用CT或MRI监测,并存在对监测指征和成本效益的误解及多种障碍。

要点

  • 多数基层医疗提供者自行进行肝细胞癌监测,但三分之一将监测转交亚专科医生。
  • 提供者认为超声联合甲胎蛋白检测对早期肿瘤检测高效,但对该组合用于多数患者进行评估。
  • 对非酒精性脂肪性肝炎或失代偿期肝硬化患者,提供者更可能使用CT或MRI进行监测。

核心结论

  • 网络调查显示基层医疗提供者报告了对肝细胞癌监测的误解和障碍,提示需要包括提供者教育在内的干预措施以提高临床实践中肝细胞癌监测的有效性。

研究设计与样本

  • 研究为网络调查,于2017年6月至2017年12月在2家三级转诊中心对133名基层医疗提供者进行,调查问卷改编自预测试调查。

主要发现

  • 提供者层面应答率为75%,诊所层面应答率为100%(133名提供者)。
  • 多数基层医疗提供者自行进行肝细胞癌监测,但三分之一将监测转交亚专科医生并将患者转诊至肝病门诊。
  • 提供者认为超声联合甲胎蛋白分析对早期肿瘤检测高度有效,并报告对多数患者使用该联合检测进行评估。
  • 对于非酒精性脂肪性肝炎或失代偿期肝硬化患者,基层医疗提供者更可能使用基于计算机断层扫描或磁共振成像的监测。
  • 多数提供者认为肝细胞癌监测对早期肿瘤检测和增加生存有效,但希望获得更多高质量证据来描述筛查的获益和危害。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Low rates of hepatocellular carcinoma (HCC) surveillance are primarily due to provider-related process failures. However, few studies have evaluated primary care provider (PCP) practice patterns, attitudes, and barriers to HCC surveillance at academic tertiary care referral centers. METHODS: We conducted a web-based survey of PCPs at 2 tertiary care referral centers (133 providers) from June 2017 through December 2017. The survey was adapted from pretested surveys and included questions about practice patterns, attitudes, and barriers to HCC surveillance. We used the Fisher exact and Mann-Whitney rank-sum tests to identify factors associated with adherence to HCC surveillance recommendations, for categoric and continuous variables, respectively. RESULTS: We obtained a provider-level response rate of 75% and clinic-level response rate of 100% (133 providers). Whereas most PCPs performed HCC surveillance themselves, one-third deferred surveillance to subspecialists and referred patients to a hepatology clinic. Providers believed the combination of ultrasound and α-fetoprotein analysis to be highly effective for early stage tumor detection and reported using the combination for assessment of most patients. However, PCPs were more likely to use computed tomography- or magnetic resonance imaging-based surveillance for patients with nonalcoholic steatohepatitis or decompensated cirrhosis. Most providers believed HCC surveillance to be efficacious for early tumor detection and increasing survival. However, they desired increased high-quality evidence to characterize screening benefits and harms. Providers expressed notable misconceptions about HCC surveillance, including the role for measurement of liver enzyme levels in HCC surveillance and cost effectiveness of surveillance in patients without cirrhosis. They also reported barriers, including not being up to date on HCC surveillance recommendations, limited time in the clinic, and competing clinical concerns. CONCLUSIONS: In a web-based survey, PCPs reported misconceptions and barriers to HCC surveillance. This indicates the need for interventions, including provider education, to improve HCC surveillance effectiveness in clinical practice.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Simmons OL, Feng Y, Parikh ND, et al. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2018. PMID: 30056183. doi:10.1016/j.cgh.2018.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。